Future studies should delineate the exact mechanistic relationship between the different levels of neural organization and may include additional disease groups to discern whether the observed effects are specific to STXBP1 syndrome or a more general feature of syndromes characterized by similar symptoms. This evidence concerns the gene STXBP1 and Down syndrome.